MIMS2 and neoplasm: In our findings, FAM210B overexpression promoted the expression of IFN-α/β and STAT1, inhibited EMT, a key process in tumor cell metastasis, and reduced the expression of the endothelial marker CD31 in mouse tumor tissues.